John C. Obenauer

This study shows that moderate global lowering of mutant Huntingtin in a HD mouse model delays some deficits but benefits diminish over time, suggesting long-term mHtt lowering may be needed for sustained benefit.

The paper analyzes RNA-seq and proteomics data from Huntington disease mouse models to identify disease-specific signatures in the striatum and liver, revealing gender effects and improved proteomics analysis methods.